Cliff Asness's FHTX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 66,239 shares of Foghorn Therapeutics Inc. (FHTX) worth $323,247, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in FHTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 33,679 shares. Largest reduction occurred in Q1 2023, reducing 39,817 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Foghorn Therapeutics (FHTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Foghorn Therapeutics (FHTX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +33,679 | Add 103.44% | 66,239 | $4.88 |
| Q1 2026 | +19,010 | Add 140.30% | 32,560 | $4.78 |
| Q4 2025 | -4,228 | Reduce 23.78% | 13,550 | $5.40 |
| Q3 2025 | -80 | Reduce 0.45% | 17,778 | $4.89 |
| Q2 2025 | -835 | Reduce 4.47% | 17,858 | $4.70 |
| Q1 2025 | +18,693 | New Buy | 18,693 | $3.65 |
| Q1 2023 | -39,817 | Sold Out | 0 | $0.00 |
| Q4 2022 | -30,770 | Reduce 43.59% | 39,817 | $6.38 |
| Q3 2022 | +70,587 | New Buy | 70,587 | $8.59 |
Cliff Asness's Foghorn Therapeutics Investment FAQs
Cliff Asness first purchased Foghorn Therapeutics Inc. (FHTX) in Q3 2022, acquiring 70,587 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Foghorn Therapeutics Inc. (FHTX) for 9 quarters since Q3 2022.
Cliff Asness's largest addition to Foghorn Therapeutics Inc. (FHTX) was in Q3 2022, adding 70,587 shares worth $606,000.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 66,239 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $323,247.
As of the Q2 2026 filing, Foghorn Therapeutics Inc. (FHTX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Foghorn Therapeutics Inc. (FHTX) was 70,587 shares, as reported at the end of Q3 2022.